Joint replacement surgery registry study
Part of Bones, joints & muscles clinical trials.
This study collects information from people having joint replacement surgery to track how they do over time and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a joint replacement with the main study doctor.
- You are 18 years or older.
- You can speak and read English.
- You are not in prison and are likely to come back for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is creating a registry of patients who have hip or knee replacement surgery or revision surgery at a specific hospital. The goal is to track outcomes and improve care for future patients.
This study looks at patients getting total knee replacement to treat severe knee arthritis. It follows participants over time to understand outcomes.
This is a registry study that collects information about people in the US who are getting a total joint replacement. It may help researchers understand outcomes and improve care for patients like you.
This trial is a “registry,” meaning it collects information from people who choose certain elective joint surgeries. It may help doctors better understand outcomes and safety after procedures like hip and knee operations.
This study collects information about people with “wear-and-tear” joint disease who need joint replacement. The goal is to better understand outcomes after surgery and improve future care.
This study looks at why osteoarthritis happens in the hip and knee by studying tissue samples taken during joint replacement surgery. If you are already scheduled for a first-time hip or knee replacement and have osteoarthritis, you may be able to join.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.